KaloCyte, Inc.

KaloCyte is developing ErythroMer, a bio-engineered artificial red blood cell substitute for treating severe blood loss when stored blood is unavailable.

  • Stage Product In Development
  • Industry Biotechnology
  • Location Baltimore, MD, USA
  • Currency USD
  • Founded March 2016
  • Employees 9
  • Incorporation Type C-corp
  • Website kalocyte.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free